Human prothrombin complex (Octapharma)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameHuman prothrombin complex (Octapharma)
Drug Alias Name4F PCC - Octapharma人凝血酶原复合物 - Octapharma4-Factor-PCC-Octapharma4 Factor Prothrombin Concentrate Complex - OctapharmaOctaplex +[7] 
ClassificationBiologics > Protein drugs > Non-recombinant coagulation factorBiologics > Blood components > Non-recombinant coagulation factor
Mechanisms of ActionCoagulation factor VII modulatorsCoagulation factor X modulatorsCoagulation factor IX modulators +[4] 
TargetsCoagulation factor VIIProthrombinCoagulation factor IX +[4] 
Therapy Area/IndicationsHemorrhagePrecursor T-Cell Lymphoblastic Leukemia-Lymphoma
Global Approved IndicationsHemorrhage
Approved Indications in ChinaN/A
Original Approved Country/TerritoryGermany
Original Approved Date2003/03/14
Country/TerritoryBosnia and HerzegovinaBulgariaCanada +[19] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesOctapharma
China Registration ClassN/A

Develop Information

Active CompaniesOctapharma
Inactive CompaniesUniversity Health Network (Uhn)
Active IndicationsHemorrhagePrecursor T-Cell Lymphoblastic Leukemia-Lymphoma
Inactive IndicationsN/A

Other Information

ATC CodeB02BD01
Related LinksN/A